HIV vaccine efficacy trial participation: men who have sex with men's experiences of risk reduction counselling and perceptions of risk behaviour change

By Guest G.   McLellan-Lemal E.   Matia D. M.   Pickard R.   Fuchs J.   Mckirnan D.   Neidig J. L.  

AIDS Care, Vol. 17, Iss. 1, 2005-01 ,pp. : 46-57

Routledge Ltd

Access to resources Recommend Favorite

Reduction of HIV-1 Load in Semen During Follow-up Study of RV144 Vaccine Trial Boosts Interest for Novel Correlates of Immune Protection in Genital Mucosa

By Spetz Anna-Lena   Chiodi Francesca  

The Journal of Infectious Diseases, Vol. 207, Iss. 8, 2013-04 ,pp. : 1189-1192

Oxford University Press

Access to resources Recommend Favorite

Improving comprehension for HIV vaccine trial information among adolescents at risk of HIV

By Murphy D. A.   Hoffman D.   Seage G. R.   Belzer M.   Xu J.   Durako S. J.   Geiger M.   Hiv The Adolescent Trials Network For   Interventions Aids  

AIDS Care, Vol. 19, Iss. 1, 2007-01 ,pp. : 42-51

Routledge Ltd

Access to resources Recommend Favorite

Lessons Learned from HIV Vaccine Clinical Efficacy Trials

By  

Current HIV Research, Vol. 11, Iss. 6, 2013-09 ,pp. : 441-449

Bentham Science Publishers

Access to resources Recommend Favorite

HIV Persistence in the Gut Mucosa of HIV-Infected Subjects Undergoing Antiretroviral Therapy Correlates with Immune Activation and Increased Levels of LPS

By  

Current HIV Research, Vol. 9, Iss. 3, 2011-04 ,pp. : 148-153

Bentham Science Publishers

Access to resources Recommend Favorite